GREY:BLMHF - Post Discussion
Post by
partystocker on Aug 19, 2022 2:25pm
Investors begin buying BLMH.c ahead of quarterly results.
It looks like investors are beginning to scoop up shares of Bloom Health Partners (CSE: BLMH) ahead of the company’s highly anticipated fiscal Q3 results. Volume is up considerably today compared to the past 2 months of trading, as the 50MA begins to show a bullish inflection.
Q3 results are expected within the next couple of weeks, and have huge potential to spur large amounts of buying. The company is presently valued at 54% of its yearly earnings to date, showing an extreme undervaluation.
BLMH.c is currently trading at $.195, valued at $9.22 million.
https://twitter.com/BloomHealthUS
Be the first to comment on this post